查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087685

動物用藥品市場：2026-2032年全球市場預測（產品類型、給藥途徑、通路、目標動物、適應症及臨床環境分類）

Veterinary Drug Market by Product Category, Route Of Administration, Distribution Channel, Animal Type, Disease Indication, Care Setting - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物用藥品市場將成長至 803.1 億美元，複合年成長率為 8.70%。

主要市場統計數據
基準年 2025 447.8億美元
預計年份：2026年 485.7億美元
預測年份 2032 803.1億美元
複合年成長率 (%) 8.70%

動物用藥品市場執行摘要

動物用藥品市場是動物健康、食品安全、伴侶動物照護和「相同健康」政策的關鍵支柱。市場需求主要來自牲畜、家禽、水產養殖、馬匹和伴侶動物的醫療需求，而美國食品藥品法律規範獸藥中心、美國農業部動植物衛生檢驗局（USDA APHIS）、歐洲藥品管理局（EMA）和各國監管機構的持續監管，則不斷影響產品品質、安全性、有效性和藥物警戒。

動物用藥品產業的變革性變化

隨著動物健康管理從被動治療轉向預防、監測和精準醫療，動物用藥品市場格局也在改變。在美國，諸如FDA的「產業指南第263號」等法規，將剩餘的具有重要醫療價值的非處方獸藥置於獸醫監管之下；在歐洲，加強對抗生素使用的管控的「(EU) 2019/6號條例」等法規，正在加速負責任的處方和合理用藥。

人工智慧（AI）的累積影響

人工智慧（AI）正開始影響動物用藥品的價值鏈，預計短期內其影響最大的領域包括藥物發現、標靶識別、臨床試驗設計、藥物安全性監測、診斷決策支援和精準動物醫學。只要資料集經過檢驗並符合適用的資料保護、品管和獸醫法規，人工智慧模型即可輔助化合物篩檢、真實世界資料（REW）分析、不利事件模式檢測以及診斷資料與治療方案的整合。

主要區域洞察：亞太地區、北美地區、拉丁美洲地區、歐洲地區、中東和非洲地區

亞太地區涵蓋中國、印度、日本、韓國、澳洲和東協市場，是成長最快的地區之一，主要得益於其大規模的畜牧業規模、不斷擴張的寵物養殖業和蓬勃發展的水產養殖業。糧農組織統計資料庫（FAOSTAT）和各國農業資料集均顯示，該地區家禽、生豬、​​乳牛和水產養殖業規模龐大，而疾病預防、疫苗、驅蟲藥和感染疾病物的合理使用是當前最迫切的需求。該地區也面臨跨國動物疫病的反覆威脅，因此，監測、生物安全、獸用生技藥品以及對基本藥物的規範化取得具有重要的戰略意義。

來自主要組織（東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約）的見解

東協市場正受惠於家禽、水產養殖和生豬養殖的現代化，對疫苗、驅蟲藥、生物安全相關療法和已通過核准的感染疾病物的需求尤其集中。疾病預防在高密度養殖系統中尤其重要，各國抗菌素抗藥性計畫也日益重視獸醫監管和合理用藥。海灣合作理事會（GCC）成員國正加大對糧食安全、乳製品生產、駱駝和馬匹健康以及規範進口管道的投資，這為高品質獸藥、生技藥品、診斷療法和低溫運輸配送創造了機會。

對主要動物用藥品市場關鍵國家的洞察

美國在動物醫藥創新、監管清晰度和伴侶動物療法方面處於主導地位，其食品藥物管理局中心 (FDA CVM) 和農業部動物用藥品衛生檢驗局 (USDA APHIS) 分別對藥品和生技藥品進行獨立監管。加拿大擁有成熟的動物衛生體系，對牲畜和伴侶動物的需求強勁，並得到聯邦動物用藥品審查和食品安全管理的支持。在墨西哥，動物用藥品的使用與家禽、豬、牛以及跨境蛋白質貿易密切相關，因此疾病控制和殘留限量合規是核心問題。巴西是世界領先的牛肉和家禽出口國之一，是一個戰略市場，因此疾病控制、疫苗接種、驅蟲藥使用以及符合出口標準的殘留控制商業性至關重要。

為動物用藥品行業領導者提供的實用建議

行業領導者應優先考慮符合監管要求的產品系列，滿足合理使用抗生素、殘留限量、強制性藥物安全監測和良好生產規範 (GMP) 標準的要求。投資應重點關注疫苗、驅蟲藥、皮膚病學、疼痛管理、慢性病治療、生殖健康以及物種特異性製劑等領域，這些領域的臨床需求和飼主/生產商的支付意願均已明確。

調查方法

本調查方法結合了基於監管機構、獸醫協會、政府間機構、科學文獻、行業資料庫和公開資訊的二手資料研究以及系統的市場分析。主要資訊來源包括美國食品藥物管理局獸醫中心 (FDA CVM)、美國農業部動植物衛生檢驗局 (USDA APHIS)、歐洲藥品管理局 (EMA)、各國獸醫主管部門、世界動物衛生組織 (WOAH)、聯合國糧農組織 (FAO)、世界衛生組織 (WHO)、國際食品轉碼器指南、抗菌抗藥性計畫、抗菌抗藥性計畫以及同行評審的動物健康研究。

結論

動物用藥品市場正朝著更加重視預防、監管更加嚴格、數位化程度更高以及更加重視治療效果的方向發展。那些兼具科學信譽、合理使用抗生素、穩定供應、完善的藥物安全監測以及以區域為導向的商業化策略的公司，最能把握這一成長機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：動物用藥品市場：依產品類型

  • 抗感染藥物
    • 抗生素
    • 抗真菌藥物
    • 抗病毒藥物
  • 抗發炎藥
  • 殺蟲劑
    • 體外寄生蟲控制劑
    • 體內寄生蟲控制劑
    • 內皮苷
  • 疫苗
    • 基礎疫苗
    • 非必要疫苗
    • 自製疫苗
  • 抗發炎/疼痛管理
    • NSAIDs
    • 皮質類固醇
    • 止痛藥
  • 荷爾蒙與生殖健康
  • 皮膚科
  • 消化器官系統
    • 止吐藥
    • 止瀉

第8章：動物用藥品市場：依給藥途徑分類

  • 吸入
  • 腸外
    • 肌肉內部
    • 皮下
    • 靜脈
    • 皮內給藥
  • 口服
    • 片劑和膠囊
    • 口服液體藥物
    • 咀嚼片
    • 添加藥物的飼料和添加藥物的水
  • 外用
    • 乳膏和軟膏
    • 噴
  • 眼科

第9章：動物用藥品市場：依通路分類

  • 網路藥房
  • 零售藥房
  • 動物醫院
  • 飼料和農業用品商店
  • 政府機關採購

第10章：動物用藥品市場：依目標動物分類

  • 伴侶動物
    • 狗
    • 貓
    • 小型哺乳動物
      • 兔子
      • 天竺鼠
      • 雪貂
    • 鳥
      • 鸚鵡
      • 雀形目
    • 異域動物
      • 爬蟲類
      • 兩棲類
  • 家畜
    • 牛
      • 乳牛
      • 肉牛
    • 豬
      • 種豬
      • 肥育豬
    • 家禽
      • 肉雞
      • 產蛋母雞
    • 小反芻動物
      • 羊
      • 山羊
    • 水產養殖
      • 淡水
      • 海水
  • 馬
    • 馬
    • 驢和騾子
  • 實驗動物
  • 動物園/野生動物

第11章動物用藥品市場：依適應症分類

  • 感染疾病
  • 皮膚病
  • 呼吸系統疾病
  • 消化系統疾病
  • 肌肉骨骼疾病
  • 生殖疾病
  • 神經病變
  • 眼科疾病

第12章動物用藥品市場：依醫療環境分類

  • 伴侶動物醫療保健
  • 畜牧業
  • 水產養殖場
  • 研究機構
  • 收容所和救援組織
  • 動物園和野生動物保護區

第13章：動物用藥品市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章動物用藥品市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章動物用藥品市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Ceva Sante Animale
  • Virbac SA
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation
  • Norbrook Group
  • Vetoquinol Group
  • Neogen Corporation
  • Chanelle Pharma
  • Aurora Pharmaceutical, Inc.
  • Biogenesis Bago SA
  • Biovac Ltd.
  • China Animal Husbandry Industry Co., Ltd.
  • ECO Animal Health Group PLC
  • Heska Corporation by Mars, Incorporated
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Laboratorio Drag Pharma Chile Invetec SA
  • Teknofarma Srl
  • Vetpharma Animal Health SL by Insud Pharma SLU
  • Zendal Group
Product Code: MRR-034B50030391

The Veterinary Drug Market is projected to grow by USD 80.31 billion at a CAGR of 8.70% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 44.78 billion
Estimated Year [2026] USD 48.57 billion
Forecast Year [2032] USD 80.31 billion
CAGR (%) 8.70%

Veterinary Drug Market Executive Summary

The veterinary drug market is a critical pillar of animal health, food security, companion animal care, and One Health policy. Demand is supported by the medical needs of livestock, poultry, aquaculture, equine, and companion animals, while regulatory oversight from agencies such as the U.S. FDA Center for Veterinary Medicine, USDA APHIS, the European Medicines Agency, and national authorities continues to shape product quality, safety, efficacy, and pharmacovigilance.

Growth in veterinary pharmaceuticals is being driven by the rising burden of infectious and parasitic diseases, higher pet health spending, expanding animal protein consumption, and the need to protect herd productivity. According to WOAH, animal diseases can affect livestock production, trade continuity, and public health, reinforcing the importance of approved veterinary medicines, vaccines, diagnostics-linked treatment, and responsible antimicrobial use. At the same time, the market is shifting toward preventive care, prescription parasiticides, targeted anti-infective stewardship, dermatology therapies, pain management, reproductive health products, and species-specific formulations that align with modern veterinary practice.

Transformative Shifts in the Veterinary Drug Landscape

The veterinary drug landscape is transforming as animal health moves from reactive treatment to prevention, surveillance, and precision care. Regulations such as FDA Guidance for Industry #263, which moved remaining over-the-counter medically important antimicrobials for animals under veterinary oversight in the United States, and Regulation (EU) 2019/6, which strengthened antimicrobial-use controls in Europe, are accelerating responsible prescribing and stewardship.

Manufacturers are also adapting to changes in distribution and care delivery. E-commerce, veterinary clinic networks, telehealth-supported prescribing where permitted, and direct relationships with producers are reshaping access to approved products. Across livestock and companion animal segments, the strongest positioning is shifting toward portfolios that combine clinical efficacy, regulatory compliance, residue management, ease of administration, cold-chain reliability, and measurable outcomes.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the veterinary drug value chain, with the highest near-term impact in drug discovery, target identification, clinical trial design, pharmacovigilance, diagnostic decision support, and precision livestock health. AI-enabled models can help screen compounds, analyze real-world evidence, detect adverse event patterns, and connect diagnostic data with treatment protocols, provided that datasets are validated and compliant with applicable data protection, quality management, and veterinary regulations.

In commercial practice, AI is strengthening disease surveillance through herd monitoring, wearable sensors, imaging tools, laboratory data, and production analytics. These capabilities support earlier intervention, better antimicrobial stewardship, improved inventory planning, and more consistent treatment decisions. The cumulative impact is not the replacement of veterinarians, but the creation of evidence-led workflows that help veterinarians, producers, and pet owners use veterinary drugs more responsibly and effectively.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a high-priority growth region because China, India, Japan, South Korea, Australia, and ASEAN markets combine large livestock populations, expanding pet ownership, and active aquaculture production. FAOSTAT and national agricultural datasets consistently show the region's scale in poultry, swine, dairy, and aquaculture, making disease prevention, vaccines, parasiticides, and anti-infective stewardship central to demand. The region also faces recurring pressure from transboundary animal diseases, which increases the strategic importance of surveillance, biosecurity, veterinary biologics, and regulated access to essential medicines.

North America remains one of the most regulated and innovation-led veterinary drug markets, supported by strong companion animal spending, advanced livestock production, and defined oversight from FDA CVM, USDA APHIS, Health Canada, and state-level veterinary boards. Latin America, led by Brazil and Mexico, is closely tied to beef, poultry, swine, and export-oriented protein supply chains, where residue compliance, disease control, and herd health programs are essential to market access and productivity.

Europe is shaped by rigorous pharmacovigilance, antimicrobial controls, and sustainability requirements under EU and national frameworks, with Regulation (EU) 2019/6 reinforcing prudent use of veterinary medicinal products. The Middle East is expanding demand through food security investments, dairy and poultry modernization, camel and equine health, and companion animal care in urban centers. Africa presents long-term potential linked to livestock disease control, vaccine access, public-sector programs, and the need to reduce productivity losses associated with endemic and transboundary animal diseases, including those prioritized by WOAH and national veterinary services.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are benefiting from poultry, aquaculture, and swine modernization, with demand concentrated in vaccines, parasiticides, biosecurity-linked therapies, and approved anti-infectives. Disease prevention is especially important in dense production systems, while national antimicrobial resistance action plans are increasing attention on veterinary oversight and responsible use. GCC countries are investing in food security, dairy production, camel and equine health, and regulated import pathways, creating opportunities for premium veterinary products, biologics, diagnostics-linked treatment, and cold-chain distribution.

The European Union remains a benchmark for veterinary drug regulation, particularly through Regulation (EU) 2019/6 and coordinated pharmacovigilance, which influence product authorization, antimicrobial stewardship, and post-market monitoring. BRICS markets combine major animal protein production, large companion animal populations, and diverse regulatory maturity, making local registration strategy, quality compliance, and manufacturing partnerships important. G7 markets are characterized by advanced veterinary infrastructure, high compliance expectations, and strong innovation adoption, while NATO countries overlap with many high-income regulated markets where supply resilience, biosecurity, and public health preparedness influence animal health policy and veterinary medicine availability.

Key Country Insights Across Major Veterinary Drug Markets

The United States leads in veterinary drug innovation, regulatory clarity, and companion animal therapeutics, with FDA CVM and USDA APHIS providing distinct oversight for drugs and biologics. Canada has a mature animal health system with strong livestock and companion animal demand, supported by federal veterinary drug review and food safety controls. Mexico links veterinary drug use to poultry, swine, cattle, and cross-border protein trade, where disease management and residue compliance remain central. Brazil is a strategic market because it is one of the world's most important beef and poultry exporters, making disease control, vaccination, parasiticide use, and export-compliant residue management commercially critical.

The United Kingdom, Germany, France, Italy, and Spain combine advanced veterinary services with strict European antimicrobial and pharmacovigilance standards, supporting demand for approved companion animal medicines, livestock vaccines, dermatology products, pain therapies, and preventive health solutions. Russia has substantial livestock production and domestic supply priorities, increasing the importance of local registration, supply continuity, and disease control. China and India are scale markets with significant livestock, aquaculture, and companion animal opportunities, though registration pathways, pricing dynamics, and local competition require careful market entry planning. Japan, Australia, and South Korea are high-compliance markets where premium companion animal therapies, vaccines, parasiticides, biosecurity, and evidence-based prescribing are especially important.

Actionable Recommendations for Veterinary Drug Industry Leaders

Industry leaders should prioritize regulatory-ready portfolios that align with antimicrobial stewardship, residue requirements, pharmacovigilance obligations, and Good Manufacturing Practice expectations. Investment should focus on vaccines, parasiticides, dermatology, pain management, chronic disease therapies, reproductive health, and species-specific formulations where clinical need and owner or producer willingness to pay are clear.

Companies should strengthen local registration expertise, diversify manufacturing and active ingredient sourcing, and build resilient cold-chain and clinic-facing distribution. Partnerships with veterinarians, producer groups, diagnostic providers, universities, and digital health providers can improve adoption, generate real-world evidence, and support differentiated value propositions in both livestock and companion animal segments. Leaders should also embed antimicrobial stewardship metrics, adverse event monitoring, and product education into commercialization to strengthen trust with regulators, veterinarians, producers, and pet owners.

Research Methodology

The research methodology combines secondary research from regulatory agencies, veterinary associations, intergovernmental organizations, scientific literature, trade databases, and public disclosures with structured market interpretation. Key sources include FDA CVM, USDA APHIS, EMA, national veterinary authorities, WOAH, FAO, WHO, Codex Alimentarius guidance, antimicrobial resistance action plans, and peer-reviewed animal health research.

Market assessment is developed through triangulation of regulatory developments, disease burden indicators, animal population trends, livestock production patterns, companion animal care dynamics, product approvals, distribution shifts, and expert-led validation. This approach supports data-backed insights without relying on unverified assumptions, unsupported market claims, market sizing, market share statements, or forecasting.

Conclusion

The veterinary drug market is becoming more prevention-driven, regulated, digitally enabled, and outcome-focused. Companies that combine scientific credibility, responsible antimicrobial practices, reliable supply, strong pharmacovigilance, and region-specific commercialization strategies are best positioned to capture growth.

As animal health becomes more closely linked to food security, public health, trade continuity, and sustainability, veterinary drug manufacturers must deliver products that meet clinical, regulatory, and economic expectations. The strongest opportunities will favor organizations that convert evidence, compliance, and innovation into trusted therapeutic value for veterinarians, producers, and pet owners.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Drug Market, by Product Category

  • 7.1. Anti-Infectives
    • 7.1.1. Antibiotics
    • 7.1.2. Antifungals
    • 7.1.3. Antivirals
  • 7.2. Anti-Inflammatories
  • 7.3. Parasiticides
    • 7.3.1. Ectoparasiticides
    • 7.3.2. Endoparasiticides
    • 7.3.3. Endectocides
  • 7.4. Vaccines
    • 7.4.1. Core Vaccines
    • 7.4.2. Non-Core Vaccines
    • 7.4.3. Autogenous Vaccines
  • 7.5. Anti-Inflammatory & Pain Management
    • 7.5.1. NSAIDs
    • 7.5.2. Corticosteroids
    • 7.5.3. Analgesics
  • 7.6. Hormones & Reproductive Health
  • 7.7. Dermatology
  • 7.8. Gastrointestinal
    • 7.8.1. Antiemetics
    • 7.8.2. Antidiarrheals

8. Veterinary Drug Market, by Route Of Administration

  • 8.1. Inhalation
  • 8.2. Parenteral
    • 8.2.1. Intramuscular
    • 8.2.2. Subcutaneous
    • 8.2.3. Intravenous
    • 8.2.4. Intradermal
  • 8.3. Oral
    • 8.3.1. Tablets & Capsules
    • 8.3.2. Oral Liquids
    • 8.3.3. Chewables
    • 8.3.4. Medicated Feed & Water
  • 8.4. Topical
    • 8.4.1. Creams & Ointments
    • 8.4.2. Sprays
  • 8.5. Ophthalmic

9. Veterinary Drug Market, by Distribution Channel

  • 9.1. Online Pharmacies
  • 9.2. Retail Pharmacies
  • 9.3. Veterinary Hospitals
  • 9.4. Feed & Farm Supply Stores
  • 9.5. Government & Institutional Procurement

10. Veterinary Drug Market, by Animal Type

  • 10.1. Companion Animals
    • 10.1.1. Dogs
    • 10.1.2. Cats
    • 10.1.3. Small Mammals
      • 10.1.3.1. Rabbits
      • 10.1.3.2. Guinea Pigs
      • 10.1.3.3. Ferrets
    • 10.1.4. Birds
      • 10.1.4.1. Psittacines
      • 10.1.4.2. Passerines
    • 10.1.5. Exotics
      • 10.1.5.1. Reptiles
      • 10.1.5.2. Amphibians
  • 10.2. Livestock Animals
    • 10.2.1. Cattle
      • 10.2.1.1. Dairy Cattle
      • 10.2.1.2. Beef Cattle
    • 10.2.2. Swine
      • 10.2.2.1. Breeding Swine
      • 10.2.2.2. Finisher Swine
    • 10.2.3. Poultry
      • 10.2.3.1. Broilers
      • 10.2.3.2. Layers
    • 10.2.4. Small Ruminants
      • 10.2.4.1. Sheep
      • 10.2.4.2. Goats
    • 10.2.5. Aquaculture
      • 10.2.5.1. Freshwater
      • 10.2.5.2. Marine
  • 10.3. Equines
    • 10.3.1. Horses
    • 10.3.2. Donkeys & Mules
  • 10.4. Laboratory Animals
  • 10.5. Zoo & Wildlife Animals

11. Veterinary Drug Market, by Disease Indication

  • 11.1. Infectious Diseases
  • 11.2. Dermatological Disorders
  • 11.3. Respiratory Disorders
  • 11.4. Gastrointestinal Disorders
  • 11.5. Musculoskeletal Disorders
  • 11.6. Reproductive Disorders
  • 11.7. Neurological Disorders
  • 11.8. Ophthalmic Disorders

12. Veterinary Drug Market, by Care Setting

  • 12.1. Companion Animal Practice
  • 12.2. Livestock Production Operations
  • 12.3. Aquaculture Farms
  • 12.4. Research Institutions
  • 12.5. Shelters & Rescue Organizations
  • 12.6. Zoos & Wildlife Centers

13. Veterinary Drug Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Veterinary Drug Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Veterinary Drug Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Zoetis Inc.
  • 17.2. Merck & Co., Inc.
  • 17.3. Boehringer Ingelheim International GmbH
  • 17.4. Elanco Animal Health Incorporated
  • 17.5. Ceva Sante Animale
  • 17.6. Virbac S.A.
  • 17.7. Dechra Pharmaceuticals PLC
  • 17.8. Phibro Animal Health Corporation
  • 17.9. Norbrook Group
  • 17.10. Vetoquinol Group
  • 17.11. Neogen Corporation
  • 17.12. Chanelle Pharma
  • 17.13. Aurora Pharmaceutical, Inc.
  • 17.14. Biogenesis Bago S.A.
  • 17.15. Biovac Ltd.
  • 17.16. China Animal Husbandry Industry Co., Ltd.
  • 17.17. ECO Animal Health Group PLC
  • 17.18. Heska Corporation by Mars, Incorporated
  • 17.19. Hester Biosciences Limited
  • 17.20. Indian Immunologicals Ltd.
  • 17.21. Intas Pharmaceuticals Ltd.
  • 17.22. Laboratorio Drag Pharma Chile Invetec S.A.
  • 17.23. Teknofarma S.r.l.
  • 17.24. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • 17.25. Zendal Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY DRUG MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY DRUG MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY DRUG MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY DRUG MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY DRUG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VETERINARY DRUG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VETERINARY DRUG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL VETERINARY DRUG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTIFUNGALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANTIFUNGALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTIFUNGALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANTIVIRALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTIVIRALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANTIVIRALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOPARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDECTOCIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDECTOCIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDECTOCIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORE VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CORE VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORE VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-CORE VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-CORE VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NON-CORE VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AUTOGENOUS VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AUTOGENOUS VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AUTOGENOUS VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANTI-INFLAMMATORY & PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTI-INFLAMMATORY & PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANTI-INFLAMMATORY & PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NSAIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NSAIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NSAIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANALGESICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANALGESICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HORMONES & REPRODUCTIVE HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HORMONES & REPRODUCTIVE HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HORMONES & REPRODUCTIVE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DERMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DERMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTIEMETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANTIEMETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTIEMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANTIDIARRHEALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTIDIARRHEALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANTIDIARRHEALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INHALATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRADERMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTRADERMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRADERMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL TABLETS & CAPSULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ORAL LIQUIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ORAL LIQUIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ORAL LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CHEWABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CHEWABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CHEWABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICATED FEED & WATER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICATED FEED & WATER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICATED FEED & WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CREAMS & OINTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SPRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SPRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SPRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL OPHTHALMIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL OPHTHALMIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL OPHTHALMIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL FEED & FARM SUPPLY STORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL FEED & FARM SUPPLY STORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL FEED & FARM SUPPLY STORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL GOVERNMENT & INSTITUTIONAL PROCUREMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL GOVERNMENT & INSTITUTIONAL PROCUREMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL GOVERNMENT & INSTITUTIONAL PROCUREMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SMALL MAMMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL SMALL MAMMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL SMALL MAMMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL RABBITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL RABBITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL RABBITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL GUINEA PIGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL GUINEA PIGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL GUINEA PIGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL FERRETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL FERRETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL FERRETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIRDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL BIRDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIRDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PSITTACINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PSITTACINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PSITTACINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PASSERINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PASSERINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PASSERINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL EXOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL EXOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL EXOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL REPTILES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL REPTILES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL REPTILES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL AMPHIBIANS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL AMPHIBIANS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL AMPHIBIANS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL DAIRY CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL DAIRY CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL DAIRY CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL BEEF CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL BEEF CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL BEEF CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL BREEDING SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL BREEDING SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL BREEDING SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL FINISHER SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL FINISHER SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL FINISHER SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL BROILERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL BROILERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL BROILERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL LAYERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL LAYERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL LAYERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL SMALL RUMINANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL SMALL RUMINANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL SMALL RUMINANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL SHEEP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL FRESHWATER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL FRESHWATER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL FRESHWATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL MARINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL MARINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL MARINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL EQUINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL EQUINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL EQUINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL HORSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL HORSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL DONKEYS & MULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL DONKEYS & MULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL DONKEYS & MULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL LABORATORY ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL LABORATORY ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL LABORATORY ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL ZOO & WILDLIFE ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL ZOO & WILDLIFE ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL ZOO & WILDLIFE ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL DERMATOLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL OPHTHALMIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL OPHTHALMIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL OPHTHALMIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL COMPANION ANIMAL PRACTICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL COMPANION ANIMAL PRACTICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL COMPANION ANIMAL PRACTICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL LIVESTOCK PRODUCTION OPERATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL LIVESTOCK PRODUCTION OPERATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL LIVESTOCK PRODUCTION OPERATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL SHELTERS & RESCUE ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL SHELTERS & RESCUE ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 274. GLOBAL SHELTERS & RESCUE ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. GLOBAL ZOOS & WILDLIFE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL ZOOS & WILDLIFE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 277. GLOBAL ZOOS & WILDLIFE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL VETERINARY DRUG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY BIRDS, 2018-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2018-2032 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY EQUINES, 2018-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 308. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 310. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 312. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 314. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 316. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 317. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 319. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
  • TABLE 320. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY BIRDS, 2018-2032 (USD MILLION)
  • TABLE 321. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2018-2032 (USD MILLION)
  • TABLE 322. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 323. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 324. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 325. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 326. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 327. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 328. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY EQUINES, 2018-2032 (USD MILLION)
  • TABLE 329. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 330. NORTH AMERICA VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 332. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 333. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 334. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 335. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 336. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 337. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 338. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 339. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 340. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 341. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 342. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 343. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 344. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 345. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
  • TABLE 346. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY BIRDS, 2018-2032 (USD MILLION)
  • TABLE 347. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2018-2032 (USD MILLION)
  • TABLE 348. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 349. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 350. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 351. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 352. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 353. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 354. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY EQUINES, 2018-2032 (USD MILLION)
  • TABLE 355. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 356. LATIN AMERICA VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 357. EUROPE VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 358. EUROPE VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 359. EUROPE VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 360. EUROPE VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 361. EUROPE VETERINARY DRUG MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 362. EUROPE VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 363. EUROPE VETERINARY DRUG MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
  • TABLE 364. EUROPE VETERINARY DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 365. EUROPE VETERINARY DRUG MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
  • TABLE 366. EUROPE VETERINARY DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 367. EUROPE VETERINARY DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 368. EUROPE VETERINARY DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 369. EUROPE VETERINARY DRUG MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 370. EUROPE VETERINARY DRUG MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 371. EUROPE VETERINARY DRUG MARKET SIZE, BY SMALL MAMMALS, 2018-2032 (USD MILLION)
  • TABLE 372. EUROPE VETERINARY DRUG MARKET SIZE, BY BIRDS, 2018-2032 (USD MILLION)
  • TABLE 373. EUROPE VETERINARY DRUG MARKET SIZE, BY EXOTICS, 2018-2032 (USD MILLION)
  • TABLE 374. EUROPE VETERINARY DRUG MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 375. EUROPE VETERINARY DRUG MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 376. EUROPE VETERINARY DRUG MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 377. EUROPE VETERINARY DRUG MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 378. EUROPE VETERINARY DRUG MARKET SIZE, BY SMALL RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 379. EUROPE VETERINARY DRUG MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 380. EUROPE VETERINARY DRUG MARKET SIZE, BY EQUINES, 2018-2032 (USD MILLION)
  • TABLE 381. EUROPE VETERINARY DRUG MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 382. EUROPE VETERINARY DRUG MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 383. MIDDLE EAST VETERINARY DRUG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 384. MIDDLE EAST VETERINARY DRUG MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 385. MIDDLE EAST VETERINARY DRUG MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 386. MIDDLE EAST VETERINARY DRUG MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 387. MIDDLE EAST VETERINARY DRUG MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 388. MIDDLE EAST VETERINARY DRUG MARKET SIZE, BY ANTI-INFLAMMATORY & PAIN MANAGEMENT, 2018-2032 (